Fingerprint
Dive into the research topics of 'Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151
Margaret A. Fischl, Douglas D. Richman, Charles Flexner, Michael F. Para, Richard Haubrich, Aziz Karim, Patrick Yeramian, Jeanne Holden-Wiltse, Patricia M. Meehan
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations